{"entity":{"type":"insider","cik":"0002034671","url":"/insider/0002034671","json_url":"/insider/0002034671.json","name":"Mazumdar Claire","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":17,"n_filings":10,"first":"2025-10-15","last":"2026-08-12","span_basis":"filed_date"},"name_variants":[{"name":"Mazumdar Claire","source":"filing","n_filings":10,"first_seen":"2025-10-15","last_seen":"2026-08-12"}],"transactions":[{"id":9289424,"accession":"0001470831-26-000813","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001470831-26-000813","line_url":"/filing/0001470831-26-000813#line-1","is_derivative":false,"issuer_cik":"0002034671","issuer_name":"Bicara Therapeutics Inc.","issuer_ticker":"BCAX","issuer_name_source":null,"issuer_url":"/issuer/0002034671","owner_cik":"0002034671","owner_name":"Mazumdar Claire","owner_display_name":"Mazumdar Claire","owner_url":"/insider/0002034671","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":27.975,"price_display":"27.98","price_state":"stated","total_value":279750.0,"total_display":"279,750.00","total_whole":"279,750","shares_owned_after":362152.0,"shares_owned_after_display":"362,152","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-10","filed_date":"2026-08-12","scope":"insider"},{"id":5844511,"accession":"0001470831-26-000714","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001470831-26-000714","line_url":"/filing/0001470831-26-000714","is_derivative":false,"issuer_cik":"0002023658","issuer_name":"Bicara Therapeutics Inc.","issuer_ticker":"BCAX","issuer_name_source":null,"issuer_url":"/issuer/0002023658","owner_cik":"0002034671","owner_name":"Mazumdar Claire","owner_display_name":"Mazumdar Claire","owner_url":"/insider/0002034671","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":28.41983836,"price_display":"28.42","price_state":"stated","total_value":284198.3836,"total_display":"284,198.38","total_whole":"284,198","shares_owned_after":362180.0,"shares_owned_after_display":"362,180","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-10","filed_date":"2026-07-14","scope":"insider","n_lines":2},{"id":6097059,"accession":"0001628280-26-036885","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001628280-26-036885","line_url":"/filing/0001628280-26-036885","is_derivative":false,"issuer_cik":"0002023658","issuer_name":"Bicara Therapeutics Inc.","issuer_ticker":"BCAX","issuer_name_source":null,"issuer_url":"/issuer/0002023658","owner_cik":"0002034671","owner_name":"Mazumdar Claire","owner_display_name":"Mazumdar Claire","owner_url":"/insider/0002034671","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":20.038573573333334,"price_display":"20.04","price_state":"stated","total_value":300578.6036,"total_display":"300,578.60","total_whole":"300,579","shares_owned_after":365130.0,"shares_owned_after_display":"365,130","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-18","filed_date":"2026-05-20","scope":"insider","n_lines":2},{"id":5872678,"accession":"0001628280-26-026089","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001628280-26-026089","line_url":"/filing/0001628280-26-026089#line-5","is_derivative":false,"issuer_cik":"0002023658","issuer_name":"Bicara Therapeutics Inc.","issuer_ticker":"BCAX","issuer_name_source":null,"issuer_url":"/issuer/0002023658","owner_cik":"0002034671","owner_name":"Mazumdar Claire","owner_display_name":"Mazumdar Claire","owner_url":"/insider/0002034671","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":23.6097,"price_display":"23.61","price_state":"stated","total_value":354145.5,"total_display":"354,145.50","total_whole":"354,146","shares_owned_after":362152.0,"shares_owned_after_display":"362,152","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-20","filed_date":"2026-04-20","scope":"insider"},{"id":6150271,"accession":"0001628280-26-020236","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001628280-26-020236","line_url":"/filing/0001628280-26-020236#line-6","is_derivative":false,"issuer_cik":"0002023658","issuer_name":"Bicara Therapeutics Inc.","issuer_ticker":"BCAX","issuer_name_source":null,"issuer_url":"/issuer/0002023658","owner_cik":"0002034671","owner_name":"Mazumdar Claire","owner_display_name":"Mazumdar Claire","owner_url":"/insider/0002034671","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1596.0,"shares_display":"1,596","price_per_share":18.9513,"price_display":"18.95","price_state":"stated","total_value":30246.2748,"total_display":"30,246.27","total_whole":"30,246","shares_owned_after":339392.0,"shares_owned_after_display":"339,392","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-20","filed_date":"2026-03-20","scope":"insider"},{"id":6150265,"accession":"0001628280-26-020236","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001628280-26-020236","line_url":"/filing/0001628280-26-020236#line-4","is_derivative":false,"issuer_cik":"0002023658","issuer_name":"Bicara Therapeutics Inc.","issuer_ticker":"BCAX","issuer_name_source":null,"issuer_url":"/issuer/0002023658","owner_cik":"0002034671","owner_name":"Mazumdar Claire","owner_display_name":"Mazumdar Claire","owner_url":"/insider/0002034671","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6905.0,"shares_display":"6,905","price_per_share":18.7842,"price_display":"18.78","price_state":"stated","total_value":129704.901,"total_display":"129,704.90","total_whole":"129,705","shares_owned_after":339392.0,"shares_owned_after_display":"339,392","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-19","filed_date":"2026-03-20","scope":"insider"},{"id":6150259,"accession":"0001628280-26-020236","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-26-020236","line_url":"/filing/0001628280-26-020236#line-2","is_derivative":false,"issuer_cik":"0002023658","issuer_name":"Bicara Therapeutics Inc.","issuer_ticker":"BCAX","issuer_name_source":null,"issuer_url":"/issuer/0002023658","owner_cik":"0002034671","owner_name":"Mazumdar Claire","owner_display_name":"Mazumdar Claire","owner_url":"/insider/0002034671","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6499.0,"shares_display":"6,499","price_per_share":18.8359,"price_display":"18.84","price_state":"stated","total_value":122414.5141,"total_display":"122,414.51","total_whole":"122,415","shares_owned_after":339392.0,"shares_owned_after_display":"339,392","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-18","filed_date":"2026-03-20","scope":"insider"},{"id":5757199,"accession":"0001628280-26-016874","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-26-016874","line_url":"/filing/0001628280-26-016874#line-2","is_derivative":false,"issuer_cik":"0002023658","issuer_name":"Bicara Therapeutics Inc.","issuer_ticker":"BCAX","issuer_name_source":null,"issuer_url":"/issuer/0002023658","owner_cik":"0002034671","owner_name":"Mazumdar Claire","owner_display_name":"Mazumdar Claire","owner_url":"/insider/0002034671","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":36766.0,"shares_display":"36,766","price_per_share":19.166,"price_display":"19.17","price_state":"stated","total_value":704657.156,"total_display":"704,657.16","total_whole":"704,657","shares_owned_after":339392.0,"shares_owned_after_display":"339,392","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-09","filed_date":"2026-03-11","scope":"insider"},{"id":6023529,"accession":"0001628280-26-015778","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001628280-26-015778","line_url":"/filing/0001628280-26-015778#line-6","is_derivative":false,"issuer_cik":"0002023658","issuer_name":"Bicara Therapeutics Inc.","issuer_ticker":"BCAX","issuer_name_source":null,"issuer_url":"/issuer/0002023658","owner_cik":"0002034671","owner_name":"Mazumdar Claire","owner_display_name":"Mazumdar Claire","owner_url":"/insider/0002034671","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3817.0,"shares_display":"3,817","price_per_share":18.7508,"price_display":"18.75","price_state":"stated","total_value":71571.8036,"total_display":"71,571.80","total_whole":"71,572","shares_owned_after":339392.0,"shares_owned_after_display":"339,392","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-06","filed_date":"2026-03-06","scope":"insider"},{"id":6023524,"accession":"0001628280-26-015778","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001628280-26-015778","line_url":"/filing/0001628280-26-015778#line-4","is_derivative":false,"issuer_cik":"0002023658","issuer_name":"Bicara Therapeutics Inc.","issuer_ticker":"BCAX","issuer_name_source":null,"issuer_url":"/issuer/0002023658","owner_cik":"0002034671","owner_name":"Mazumdar Claire","owner_display_name":"Mazumdar Claire","owner_url":"/insider/0002034671","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1786.0,"shares_display":"1,786","price_per_share":18.7369,"price_display":"18.74","price_state":"stated","total_value":33464.1034,"total_display":"33,464.10","total_whole":"33,464","shares_owned_after":339392.0,"shares_owned_after_display":"339,392","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-05","filed_date":"2026-03-06","scope":"insider"},{"id":6023517,"accession":"0001628280-26-015778","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-26-015778","line_url":"/filing/0001628280-26-015778#line-2","is_derivative":false,"issuer_cik":"0002023658","issuer_name":"Bicara Therapeutics Inc.","issuer_ticker":"BCAX","issuer_name_source":null,"issuer_url":"/issuer/0002023658","owner_cik":"0002034671","owner_name":"Mazumdar Claire","owner_display_name":"Mazumdar Claire","owner_url":"/insider/0002034671","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2631.0,"shares_display":"2,631","price_per_share":18.7338,"price_display":"18.73","price_state":"stated","total_value":49288.6278,"total_display":"49,288.63","total_whole":"49,289","shares_owned_after":339392.0,"shares_owned_after_display":"339,392","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-04","filed_date":"2026-03-06","scope":"insider"},{"id":4078886,"accession":"0002034671-25-000009","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0002034671-25-000009","line_url":"/filing/0002034671-25-000009#line-2","is_derivative":false,"issuer_cik":"0002023658","issuer_name":"Bicara Therapeutics Inc.","issuer_ticker":"BCAX","issuer_name_source":null,"issuer_url":"/issuer/0002023658","owner_cik":"0002034671","owner_name":"Mazumdar Claire","owner_display_name":"Mazumdar Claire","owner_url":"/insider/0002034671","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":41163.0,"shares_display":"41,163","price_per_share":18.8623,"price_display":"18.86","price_state":"stated","total_value":776428.8549,"total_display":"776,428.85","total_whole":"776,429","shares_owned_after":309892.0,"shares_owned_after_display":"309,892","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-24","filed_date":"2025-11-25","scope":"insider"},{"id":4188727,"accession":"0002034671-25-000006","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0002034671-25-000006","line_url":"/filing/0002034671-25-000006#line-2","is_derivative":false,"issuer_cik":"0002023658","issuer_name":"Bicara Therapeutics Inc.","issuer_ticker":"BCAX","issuer_name_source":null,"issuer_url":"/issuer/0002023658","owner_cik":"0002034671","owner_name":"Mazumdar Claire","owner_display_name":"Mazumdar Claire","owner_url":"/insider/0002034671","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24103.0,"shares_display":"24,103","price_per_share":18.8259,"price_display":"18.83","price_state":"stated","total_value":453760.6677,"total_display":"453,760.67","total_whole":"453,761","shares_owned_after":309892.0,"shares_owned_after_display":"309,892","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-16","filed_date":"2025-10-20","scope":"insider"},{"id":4858442,"accession":"0002034671-25-000003","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0002034671-25-000003","line_url":"/filing/0002034671-25-000003#line-4","is_derivative":false,"issuer_cik":"0002023658","issuer_name":"Bicara Therapeutics Inc.","issuer_ticker":"BCAX","issuer_name_source":null,"issuer_url":"/issuer/0002023658","owner_cik":"0002034671","owner_name":"Mazumdar Claire","owner_display_name":"Mazumdar Claire","owner_url":"/insider/0002034671","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13289.0,"shares_display":"13,289","price_per_share":18.842,"price_display":"18.84","price_state":"stated","total_value":250391.338,"total_display":"250,391.34","total_whole":"250,391","shares_owned_after":309892.0,"shares_owned_after_display":"309,892","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-15","filed_date":"2025-10-15","scope":"insider"},{"id":4858434,"accession":"0002034671-25-000003","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0002034671-25-000003","line_url":"/filing/0002034671-25-000003#line-2","is_derivative":false,"issuer_cik":"0002023658","issuer_name":"Bicara Therapeutics Inc.","issuer_ticker":"BCAX","issuer_name_source":null,"issuer_url":"/issuer/0002023658","owner_cik":"0002034671","owner_name":"Mazumdar Claire","owner_display_name":"Mazumdar Claire","owner_url":"/insider/0002034671","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11445.0,"shares_display":"11,445","price_per_share":18.9205,"price_display":"18.92","price_state":"stated","total_value":216545.1225,"total_display":"216,545.12","total_whole":"216,545","shares_owned_after":309892.0,"shares_owned_after_display":"309,892","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-13","filed_date":"2025-10-15","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":17,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":17,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":17},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0002023658","name":"Bicara Therapeutics Inc.","url":"/issuer/0002023658","role":"Director, Officer (Chief Executive Officer)","n_filings":10,"first_seen":"2025-10-15","last_seen":"2026-08-12"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0002034671","retrieved_at":"2026-08-22T11:26:28+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}